Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine. Warnke C, Wiendl H, Hartung H-P, Stüve O, Kieseier BC Drug Des Devel Ther. 2010; 4:117-26. Epub 2010 Jul 21. PMID: 20689698. Abstract CommentRecommendBookmarkWatch